Long-term outcome in pyridoxine-dependent epilepsy

Developmental Medicine and Child Neurology

Volumn 54, Issue 9, 2012, Pages 849-854

  Bok, Levinus A ^a   Halbertsma, Feico J ^a   Houterman, Saskia ^a   Wevers, Ron A ^b   Vreeswijk, Charlotte ^c   Jakobs, Cornelis ^d   Struys, Eduard ^d   Van Der Hoeven, Johan H ^e   Sival, Deborah A ^e   Willemsen, Michèl A ^b  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; ALPHA AMINOADIPIC SEMIALDEHYDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PYRIDOXINE; UNCLASSIFIED DRUG; VALPROIC ACID;

ADOLESCENT; ANTIQUITIN GENE; ARTICLE; CHILD; CLINICAL ARTICLE; COGNITION; CORPUS CALLOSUM; DEVELOPMENTAL STAGE; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC DISCHARGE; FEMALE; FOLLOW UP; GENE; GENOTYPE; HUMAN; INTELLIGENCE QUOTIENT; LONG TERM CARE; MALE; MENTAL DEVELOPMENT; MONOTHERAPY; MUTATION; NERVOUS SYSTEM FUNCTION; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OUTCOME ASSESSMENT; PRENATAL PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SCHOOL; SCHOOL CHILD; SEIZURE; WALKING; WHITE MATTER;

ADOLESCENT; AGE FACTORS; ALDEHYDE DEHYDROGENASE; BRAIN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CORPUS CALLOSUM; DEVELOPMENTAL DISABILITIES; DNA MUTATIONAL ANALYSIS; EPILEPSY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; PREGNANCY; PYRIDOXINE; RETROSPECTIVE STUDIES;

EID: 84865171162     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2012.04347.x     Document Type: Article

References (26)

1. Baxter P. Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK. Arch Dis Child 1999; 81: 431-3.
2. Been JV, Bok LA, Andriessen P, Renier WO. Epidemiology of pyridoxine dependent seizures in the Netherlands. Arch Dis Child 2005; 90: 1293-6.
3. Bok LA, Struys E, Willemsen MA, Been JV, Jakobs C. Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic levels. Arch Dis Child 2007; 92: 687-9.
4. Mills PB, Struys E, Jakobs C, et al. Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 2006; 12: 307-9.
5. Haenggeli CA, Girardin E, Paunier L. Pyridoxine-dependent seizures, clinical and therapeutic aspects. Eur J Pediatr 1991; 150: 452-5.
6. Bok LA, Been JV, Struys EA, Jakobs C, Rijper EA, Willemsen MA. Antenatal treatment in two Dutch families with pyridoxine-dependent seizures. Eur J Pediatr 2010; 169: 297-303.
7. Salomons GS, Bok LA, Struys EA, et al. An intriguing 'silent' mutation and a founder effect in antiquitin (ALDH7A1). Ann Neurol 2007; 62: 414-8.
8. Van der Meulen BF, Ruiter SAJ, Lutje Spelberg HC, Smrkovsky M. BSID-II-NL, Dutch Manual. Lisse, The Netherlands: Swets, 2002.
9. Tellegen PJ, Winkel M, Wijnberg-Williams BJ, Laros JA. Snijders-Oomen niet-verbale Intelligentietest, SON-R 21/2-7. Lisse, The Netherlands: Swets & Zeitlinger, 1998.
10. Kort W, Schittekatte M, Dekker PH, et al. WISC-III NL; Wechsler Intelligence Scale for Children, derde Editie NL. London: Harcourt Test Publishers, 2005.
11. Steenweg ME, Salomons GS, Yapici Z, et al. L-2-hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56 patients. Radiology 2009; 251: 856-65.
12. Bok LA, Maurits NM, Willemsen MA, et al. The EEG response to pyridoxine-IV neither identifies nor excludes pyridoxine-dependent epilepsy. Epilepsia 2010; 51: 2406-11.
13. Basura GJ, Hagland SP, Wiltse AM, Gospe SM Jr. Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry. Eur J Pediatr 2009; 168: 697-704.
14. Scharer G, Brocker C, Vasiliou V, et al. The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1. J Inherit Metab Dis 2010; 33: 571-81.
15. Baxter P, Griffiths P, Kelly T, Gardner-Medwin D. Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Dev Med Child Neurol 1996; 38: 998-1006.
16. Plecko B, Hikel C, Korenke GC, et al. Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy. Neuropediatrics 2005; 36: 200-5.
17. Ramachandrannair R, Parameswaran M. Prevalence of pyridoxine dependent seizures in south Indian children with early onset intractable epilepsy: a hospital based prospective study. Eur J Paediatr Neurol 2005; 9: 409-13.
18. Mills PB, Footitt EJ, Mills KA, et al. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain 2010; 133: 2148-59.
19. Gospe SM Jr, Hecht ST. Longitudinal MRI findings in pyridoxine-dependent seizures. Neurology 1998; 51: 74-8.
20. Kanno J, Kure S, Narisawa A, et al. Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis. Mol Genet Metab 2007; 91: 384-9.
21. Baynes K, Farias ST, Gospe SM Jr. Pyridoxine-dependent seizures and cognition in adulthood. Dev Med Child Neurol 2003; 45: 782-5.
22. Hunt AD Jr, Stokes J Jr, McCrory WW, Stroud HH. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics 1954; 13: 140-5.
23. Kluger G, Blank R, Paul K, et al. Pyridoxine-dependent epilepsy: normal outcome in a patient with late diagnosis after prolonged status epilepticus causing cortical blindness. Neuropediatrics 2008; 39: 276-9.
24. Mikati MA, Trevathan E, Krishnamoorthy KS, Lombroso CT. Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up. Electroencephalogr Clin Neurophysiol 1991; 78: 215-21.
25. Rankin PM, Harrison S, Chong WK, Boyd S, Aylett SE. Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime. Dev Med Child Neurol 2007; 49: 300-5.
26. Striano P, Battaglia S, Giordano L, et al. Two novel ALDH7A1 (antiquitin) splicing mutations associated with pyridoxine-dependent seizures. Epilepsia 2009; 50: 933-6.